Barclays’s Aesthetic Medical International Holdings AIH Stock Holding History

Barclays’s Portfolio AIH Stock Details AIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-84,754	Closed	-$58.4K	–	5441
2023 Q4	$58.4K	Buy	+84,754	New	+$54.6K	﹤0.01%	4747
2023 Q1	–	Sell	-84,754	Closed	-$109K	–	5434
2022 Q4	$109K	Hold	84,754	–	–	﹤0.01%	4172
2022 Q3	$150K	Hold	84,754	–	–	﹤0.01%	3355
2022 Q2	$181K	Hold	84,754	–	–	﹤0.01%	3493
2022 Q1	$137K	Buy	+84,754	New	+$239K	﹤0.01%	3638

Other funds holding AIH

ITVII

IDG Technology Venture Investment IV Hong Kong $58.3M AUM 89.42% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

Barclays's AIH Position: Q1 2024 in Review

Barclays sold out of Aesthetic Medical International Holdings (AIH) in Q1 2024, closing a stake of 84,754 shares — an estimated $58.4K sold.

Barclays first reported a position in AIH in Q1 2022 and held it in 5 quarters. The position peaked at $181K in Q2 2022. 5 funds tracked by Wall St. Rank hold AIH as of Q1 2024.

Barclays reported no remaining Aesthetic Medical International Holdings position as of Q1 2024 after selling out during the quarter.
Barclays sold 84,754 Aesthetic Medical International Holdings shares in Q1 2024, an estimated $58.4K.
Barclays first reported a position in Aesthetic Medical International Holdings in Q1 2022 and held it in 5 quarters.
Barclays's Aesthetic Medical International Holdings position peaked at $181K in Q2 2022.
5 funds tracked by Wall St. Rank held Aesthetic Medical International Holdings as of Q1 2024.

Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.